Light has profoundly impacted modern medicine and healthcare, with numerous
luminescent agents and imaging techniques currently being used to assess health and treat …

The excited‐state tuning of luminescent metal–organic compounds has made great
progress in the fields of optical imaging, photocatalysis, photodynamic therapy, light …

X-ray-induced afterglow and radiodynamic therapy tackle the tissue penetration issue of
optical imaging and phototherapy. However, inorganic nanophosphors used in this therapy …

Realizing efficient and ultralong room‐temperature phosphorescence (RTP) is highly
desirable but remains a challenge due to the inherent competition between excited state …

Afterglow luminescence (long persistent luminescence) holds great potential for
nonbackground molecular imaging. However, current afterglow probes are mainly …

Noncancerous diseases include a wide plethora of medical conditions beyond cancer and
are a major cause of mortality around the world. Despite progresses in clinical research …

Fluorescence imaging in the second near‐infrared (NIR‐II) window holds great promise for
in vivo visualization of amyloid‐β (Aβ) pathology, which can facilitate characterization and …

Chemotherapeutic resistance poses a significant challenge in cancer treatment, resulting in
the reduced efficacy of standard chemotherapeutic agents. Abnormal metabolism …

Self-luminescence, which eliminates the real-time external optical excitation, can effectively
avoid background autofluorescence in photoluminescence, endowing with ultrahigh signal …

Herein, we report an activatable near‐infrared (NIR) afterglow theranostic prodrug that
circumvents high background noise interference caused by external light excitation. The …